ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

STX Shield Therapeutics Plc

1.95
-0.10 (-4.88%)
21 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -4.88% 1.95 1.90 2.00 2.05 1.95 2.05 1,899,144 14:14:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.37 15.12M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 2.05p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £15.12 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.37.

Shield Therapeutics Share Discussion Threads

Showing 4851 to 4873 of 23400 messages
Chat Pages: Latest  204  203  202  201  200  199  198  197  196  195  194  193  Older
DateSubjectAuthorDiscuss
01/1/2020
10:11
Add to those pending deal announcements the business update around the 24 January and it could be that we are heading for double/triple bubble news flow over the next four weeks.

Any update on that patent defence submission? Didn’t NYB reckon the deadline was 2 January. Maybe that will be the first RNS of the year.

borromini1
01/1/2020
08:36
LOL regulatory affairs is most definitely not my area! In the short term it is all about the licensing deals in the US and China with the former clearly being the most important. A delay is not a problem; all that matters is the terms of the deal and if that takes a bit longer to negotiate then so be it.
nobbygnome
31/12/2019
12:30
Best wait for the US commercialization deal, obviously it was not going to be announced around Christmas/NY holidays. For maximum impact, wait for the markets to build up volumes and activity, say 2nd week of January onwards, no rush really, stay patient

Happy NY to all, stay healthy & wealth, a new decade ahead, of immense opportunities!

ny boy
30/12/2019
21:58
STX have mentioned a number of times about the advantages of being able to sell direct to consumers in the US, what stopped them setting up a pilot e-commerce service straight after the FDA broad approval?
borromini1
30/12/2019
21:51
Silence I guess because they didn't promise it would be done by the end of the year.

Anyway it is of no matter as a deal will most definitely come at some point soon.

nobbygnome
30/12/2019
21:45
So will we get the delay RNS, deal summary RNS or silence tomorrow?
borromini1
23/12/2019
12:18
Finncap mucking about as usual...
nobbygnome
23/12/2019
10:35
Buyers are returning, share price has dropped slightly on low selling vols, clearly another mugging going on. Still think, they will announce first week after the NY hols, still I won’t be complaining if it arrives earlier.
ny boy
23/12/2019
06:53
They have never stated a commitment for the deal mentioned what as been stated is that they are hopefull of getting a deal done by year end but not it as to be the right deal so if runs into next year so be it
best1467
21/12/2019
17:21
Actually that presentation was given just under 5 weeks ago on the 19th November; on my first look I thought it was the 9th not the 19th so apologies. Nevertheless a lot could have happened in the last 5 weeks so I wouldn't rule out an announcement next week.
nobbygnome
20/12/2019
15:22
That talk was the beginning of November so about 6 weeks ago. It is still possible for us to get a deal next week but no drama if it takes into the New Year. I have slightly increased my spreadbet position this afternoon and will keep adding if it drifts down.
nobbygnome
20/12/2019
15:11
If the deal timescale is now being referred to as ‘how long is a piece of string’ then it doesn’t sound like it’ll be this year. Why would he say that if it was imminent or inline with previous commitments. I feel it may be well into Q1 hence the share price softening a bit this week. I don’t see much downside whilst we wait and if it’s a great deal then no one will care too much
siriusbizness
20/12/2019
14:02
Should be http
crankyman
20/12/2019
13:29
Can't connect.
montyhedge
20/12/2019
08:18
Still working on the US deal. European launches now expected 2021.
crankyman
20/12/2019
08:02
This is new: hxxps://youtu.be/j7haj75OTSI
crankyman
19/12/2019
16:01
So today the price moved down to 178p/180p on fairly low volume, then someone bought 25k shares at 184p and this did not push the price up?!
secret investor
19/12/2019
06:54
Did a post ref that interview some weeks back
best1467
19/12/2019
05:47
Yes it’s previous. Just not seen it on here before. Doesn’t matter when posted, just interesting to the follow up data
peachie 74
18/12/2019
23:06
Oh, thought it was from today, should put dates on these videos
ny boy
18/12/2019
22:42
This is old. It's from October. The Medical Director talking about the long term follow up data. Sorry to bust up the party.
crankyman
18/12/2019
22:22
Was that out today?
nobbygnome
18/12/2019
22:02
Good find peachie!

Looks like all is hunky dory

Hold and wait for the US commercialization deal now

ny boy
Chat Pages: Latest  204  203  202  201  200  199  198  197  196  195  194  193  Older